{
    "root": "a70488d7-57ea-446e-89c2-87b0ecc90023",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Nuvigil",
    "value": "20221231",
    "ingredients": [
        {
            "name": "ARMODAFINIL",
            "code": "V63XWA605I"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "POVIDONE K30",
            "code": "U725QWY32X"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        }
    ],
    "indications": "NUVIGIL is indicated to improve wakefulness in adult patients with excessive sleepiness associated with obstructive sleep apnea (OSA), narcolepsy, or shift work disorder (SWD).\n                  \n                     Limitations of Use\n                  \n                  In OSA, NUVIGIL is indicated to treat excessive sleepiness and not as treatment for the underlying obstruction.  If continuous positive airway pressure (CPAP) is the treatment of choice for a patient, a maximal effort to treat with CPAP for an adequate period of time should be made prior to initiating NUVIGIL for excessive sleepiness.",
    "contraindications": "The recommended dosage of NUVIGIL for each indication is as follows: OSA or Narcolepsy: 150 mg to 250 mg once a day in the morning. ( 2.1 ) SWD: 150 mg once a day, taken approximately one hour prior to start of the work shift. ( 2.2 ) Hepatic Impairment: reduced dose in patients with severe hepatic impairment. ( 2.3 , 12.3 ) Geriatric Patients: consider lower dose. ( 2.4 , 12.3 )",
    "warningsAndPrecautions": "NUVIGIL® (armodafinil) Tablets are available as follows:\n                        50 mg:  Each round, white to off-white tablet is debossed with   on one side and \"205\" on the other.NDC 63459-205-30 – Bottles of 30\n                        150 mg: Each oval, white to off-white tablet is debossed with   on one side and \"215\" on the other.NDC 63459-215-30 – Bottles of 30\n                        200 mg: Each rounded, rectangular, white to off-white tablet is debossed with   on one side and \"220\" on the          other.NDC 63459-220-30 – Bottles of 30\n                        250 mg: Each oval, white to off-white tablet is debossed with   on one side and \"225\" on the other.NDC 63459-225-30 – Bottles of 30",
    "adverseReactions": "NUVIGIL is contraindicated in patients with known hypersensitivity to modafinil or armodafinil or its inactive ingredients [see Warnings and Precautions (5.1, 5.2, 5.3)]."
}